Spots Global Cancer Trial Database for adult pineal gland astrocytoma

Every month we try and update this database with for adult pineal gland astrocytoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Photodynamic Therapy With Porfimer Sodium in Treating Patients With Refractory Brain Tumors	NCT00002647	Brain and Centr... Metastatic Canc...	verteporfin conventional su...	3 Years - 70 Years	National Cancer Institute (NCI)
Bevacizumab in Recurrent Grade II and III Glioma	NCT01164189	Central Nervous...	Bevacizumab Temozolomide	18 Years -	European Organisation for Research and Treatment of Cancer - EORTC
Tumor Tissue Analysis in Patients Receiving Imatinib Mesylate for Malignant Glioma	NCT00401024	Brain and Centr...	imatinib mesyla... pharmacological... conventional su...	18 Years - 120 Years	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Tumors	NCT00003461	Brain and Centr... Metastatic Canc... Neuroblastoma	surgical proced... astatine At 211...	18 Years -	Duke University
18F-FDOPA PET/CT or PET/MRI in Measuring Tumors in Patients With Newly-Diagnosed or Recurrent Gliomas	NCT02175745	Adult Anaplasti... Adult Anaplasti... Adult Brain Ste... Adult Diffuse A... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Mixed Gli... Adult Oligodend... Adult Pilocytic... Adult Pineal Gl... Adult Subependy... Childhood High-... Childhood High-... Childhood Low-g... Childhood Low-g... Recurrent Adult... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child...	18F-fluoro-dihy... Positron emissi... Computed tomogr... Magnetic resona...	16 Years -	Stanford University
Tamoxifen, Carboplatin, and Topotecan in Treating Patients With CNS Metastases or Recurrent Brain or Spinal Cord Tumors	NCT00541138	Brain and Centr... Metastatic Canc... Unspecified Adu...	carboplatin tamoxifen citra... topotecan hydro... pharmacological...	18 Years -	City of Hope Medical Center
Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases	NCT02967380	Adult Anaplasti... Adult Anaplasti... Adult Anaplasti... Adult Anaplasti... Adult Brain Ste... Adult Choroid P... Adult Diffuse A... Adult Ependymob... Adult Ependymom... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Grade II ... Adult Medullobl... Adult Mixed Gli... Adult Oligodend... Adult Papillary... Adult Pineal Gl... Adult Pineoblas... Adult Primary M... Adult Supratent... Malignant Adult... Metastatic Mali... Multiple Sclero... Recurrent Adult...	Dynamic Contras... Gadobenate Dime... Gadobutrol Gadopentetate D...	18 Years -	University of Southern California
Lonafarnib and Temozolomide in Treating Patients With Recurrent Primary Supratentorial Gliomas	NCT00083096	Brain and Centr...	lonafarnib temozolomide	18 Years -	European Organisation for Research and Treatment of Cancer - EORTC
Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Tumors	NCT00003461	Brain and Centr... Metastatic Canc... Neuroblastoma	surgical proced... astatine At 211...	18 Years -	Duke University
Phase I Study of Cellular Immunotherapy for Recurrent/Refractory Malignant Glioma Using Intratumoral Infusions of GRm13Z40-2, An Allogeneic CD8+ Cytolitic T-Cell Line Genetically Modified to Express the IL 13-Zetakine and HyTK and to be Resistant to Glucocorticoids, in Combination With Interleukin-2	NCT01082926	Anaplastic Astr... Anaplastic Epen... Anaplastic Meni... Anaplastic Olig... Brain Stem Glio... Ependymoblastom... Giant Cell Glio... Glioblastoma Gliosarcoma Grade III Menin... Meningeal Heman... Mixed Glioma Pineal Gland As... Brain Tumor	therapeutic all... aldesleukin laboratory biom... positron emissi...	18 Years - 70 Years	City of Hope Medical Center
Study of Blood Samples and Risk of Infection in Patients With Newly Diagnosed Malignant Supratentorial Astrocytoma	NCT00999622	Brain and Centr... Infection	laboratory biom... questionnaire a...	18 Years -	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Bevacizumab in Recurrent Grade II and III Glioma	NCT01164189	Central Nervous...	Bevacizumab Temozolomide	18 Years -	European Organisation for Research and Treatment of Cancer - EORTC
Proton Beam Radiation Therapy in Treating Patients With Low Grade Gliomas	NCT01024907	Adult Brain Tum... Adult Brain Ste... Adult Diffuse A... Adult Ependymom... Adult Grade II ... Adult Melanocyt... Adult Meningeal... Adult Mixed Gli... Adult Oligodend... Adult Pineal Gl... Adult Pineocyto... Recurrent Adult...	proton beam rad... quality-of-life... questionnaire a...	18 Years -	Abramson Cancer Center at Penn Medicine
RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma	NCT01119599	Acoustic Schwan... Adult Anaplasti... Adult Anaplasti... Adult Anaplasti... Adult Brain Ste... Adult Choroid P... Adult Craniopha... Adult Diffuse A... Adult Ependymob... Adult Ependymom... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Grade I M... Adult Grade II ... Adult Medullobl... Adult Mixed Gli... Adult Myxopapil... Adult Oligodend... Adult Papillary... Adult Pilocytic... Adult Pineal Gl... Adult Pineoblas... Adult Pineocyto... Adult Primary M... Adult Subependy... Adult Subependy... Adult Supratent... Malignant Adult...	3-Dimensional C... Gamma-Secretase... Intensity-Modul... Laboratory Biom... Pharmacological... Temozolomide Therapeutic Con...	19 Years -	National Cancer Institute (NCI)
Erlotinib and Temsirolimus in Treating Patients With Recurrent Malignant Glioma	NCT00112736	Adult Anaplasti... Adult Anaplasti... Adult Diffuse A... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Mixed Gli... Adult Pilocytic... Adult Pineal Gl... Adult Subependy... Recurrent Adult...	erlotinib temsirolimus therapeutic con... laboratory biom... pharmacological...	18 Years -	National Cancer Institute (NCI)
Study of Tissue Samples From Patients With Glioma or Other Brain Tumors	NCT00967200	Central Nervous...	laboratory biom... pharmacogenomic...	18 Years - 120 Years	University Hospital, Montpellier
Study of Blood Samples and Risk of Infection in Patients With Newly Diagnosed Malignant Supratentorial Astrocytoma	NCT00999622	Brain and Centr... Infection	laboratory biom... questionnaire a...	18 Years -	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sunitinib in Treating Patients With Recurrent Malignant Gliomas	NCT00499473	Adult Anaplasti... Adult Diffuse A... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Mixed Gli... Adult Oligodend... Adult Pineal Gl...	sunitinib malat... pharmacological...	18 Years -	National Cancer Institute (NCI)
Use of EF5 to Measure the Oxygen Level in Tumor Cells of Patients Undergoing Surgery or Biopsy for Newly Diagnosed Supratentorial Malignant Glioma	NCT00430079	Adult Anaplasti... Adult Anaplasti... Adult Anaplasti... Adult Diffuse A... Adult Ependymom... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Mixed Gli... Adult Myxopapil... Adult Oligodend... Adult Pilocytic... Adult Pineal Gl... Adult Subependy...	etanidazole conventional su... pharmacological... laboratory biom...	18 Years -	National Cancer Institute (NCI)
Temozolomide in Treating Patients With Recurrent Glioblastoma Multiforme or Other Malignant Glioma	NCT00498927	Brain and Centr...	temozolomide protein express... reverse transcr... diagnostic labo... immunoenzyme te...	18 Years - 120 Years	Memorial Sloan Kettering Cancer Center
Study of Blood and Cheek Cell Samples From Patients With Glioma	NCT01009307	Brain and Centr...	polymorphism an... laboratory biom... medical chart r...	18 Years - 120 Years	University of California, San Francisco
Enzastaurin and Temozolomide in Treating Patients With Primary Gliomas	NCT00516607	Brain and Centr...	enzastaurin hyd... temozolomide pharmacological...	18 Years -	European Organisation for Research and Treatment of Cancer - EORTC
Veliparib and Temozolomide in Treating Patients With Recurrent Glioblastoma	NCT01026493	Brain and Centr...	temozolomide 60... temozolomide 75... ABT-888 20 mg x... ABT-888 40 mg x... Temozolomide 15... ABT-888 40 mg x...	18 Years - 120 Years	Radiation Therapy Oncology Group
Imatinib Mesylate, Vatalanib, and Hydroxyurea in Treating Patients With Recurrent or Relapsed Malignant Glioma	NCT00387933	Brain and Centr...	hydroxyurea imatinib mesyla... vatalanib	18 Years -	Duke University
Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases	NCT02967380	Adult Anaplasti... Adult Anaplasti... Adult Anaplasti... Adult Anaplasti... Adult Brain Ste... Adult Choroid P... Adult Diffuse A... Adult Ependymob... Adult Ependymom... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Grade II ... Adult Medullobl... Adult Mixed Gli... Adult Oligodend... Adult Papillary... Adult Pineal Gl... Adult Pineoblas... Adult Primary M... Adult Supratent... Malignant Adult... Metastatic Mali... Multiple Sclero... Recurrent Adult...	Dynamic Contras... Gadobenate Dime... Gadobutrol Gadopentetate D...	18 Years -	University of Southern California
Tamoxifen, Carboplatin, and Topotecan in Treating Patients With CNS Metastases or Recurrent Brain or Spinal Cord Tumors	NCT00541138	Brain and Centr... Metastatic Canc... Unspecified Adu...	carboplatin tamoxifen citra... topotecan hydro... pharmacological...	18 Years -	City of Hope Medical Center
Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) With Bevacizumab and Irinotecan for Malignant Glioma	NCT00352521	Brain and Centr...	bevacizumab irinotecan dynamic contras...	18 Years -	Duke University
Alisertib and Fractionated Stereotactic Radiosurgery in Treating Patients With Recurrent High Grade Gliomas	NCT02186509	Adult Anaplasti... Adult Anaplasti... Adult Anaplasti... Adult Brain Ste... Adult Diffuse A... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Mixed Gli... Adult Oligodend... Adult Pilocytic... Adult Pineal Gl... Adult Subependy... Recurrent Adult...	Hyperfractionat... Stereotactic ra... Alisertib Quality-of-life...	18 Years -	Thomas Jefferson University
Levetiracetam or Pregabalin in Treating Seizures in Patients Undergoing Chemotherapy and/or Radiation Therapy For Primary Brain Tumors	NCT00629889	Brain and Centr... Seizure	levetiracetam pregabalin	18 Years -	Centre Hospitalier Universitaire Vaudois
Cellular Adoptive Immunotherapy Using Genetically Modified T-Lymphocytes in Treating Patients With Recurrent or Refractory High-Grade Malignant Glioma	NCT00730613	Brain and Centr...	therapeutic aut... gene expression... laboratory biom...	18 Years - 70 Years	City of Hope Medical Center
Pharmacokinetics in Patients With Newly Diagnosed High-Grade Glioma Receiving Temozolomide and Radiation Therapy	NCT00471653	Brain and Centr... Thrombocytopeni...	temozolomide comparative gen... polymorphism an... laboratory biom... pharmacological... radiation thera...	18 Years - 120 Years	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Yoga Therapy in Treating Patients With Malignant Brain Tumors	NCT01234805	Adult Anaplasti... Adult Anaplasti... Adult Anaplasti... Adult Anaplasti... Adult Brain Ste... Adult Choroid P... Adult Diffuse A... Adult Ependymob... Adult Ependymom... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Grade II ... Adult Medullobl... Adult Meningeal... Adult Mixed Gli... Adult Oligodend... Adult Papillary... Adult Pineal Gl... Adult Pineoblas... Adult Pineocyto... Adult Supratent... Recurrent Adult...	yoga therapy questionnaire a... quality-of-life...	18 Years -	Wake Forest University Health Sciences
Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors	NCT02194452	Acoustic Schwan... Adult Anaplasti... Adult Anaplasti... Adult Anaplasti... Adult Anaplasti... Adult Brain Ste... Adult Choroid P... Adult Craniopha... Adult Diffuse A... Adult Ependymob... Adult Ependymom... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Grade I M... Adult Grade II ... Adult Medullobl... Adult Meningeal... Adult Mixed Gli... Adult Myxopapil... Adult Oligodend... Adult Papillary... Adult Pilocytic... Adult Pineal Gl... Adult Pineoblas... Adult Pineocyto... Adult Subependy... Adult Subependy... Adult Supratent... Childhood Choro... Childhood Crani... Childhood Epend... Childhood Grade... Childhood Grade... Childhood Grade... Childhood High-... Childhood High-... Childhood Infra... Childhood Low-g... Childhood Low-g... Childhood Medul... Childhood Supra... Meningeal Melan... Newly Diagnosed... Recurrent Adult... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child...	gallium Ga 68-e... positron emissi... computed tomogr... laboratory biom...	6 Months - 29 Years	University of Iowa
Tamoxifen, Carboplatin, and Topotecan in Treating Patients With CNS Metastases or Recurrent Brain or Spinal Cord Tumors	NCT00541138	Brain and Centr... Metastatic Canc... Unspecified Adu...	carboplatin tamoxifen citra... topotecan hydro... pharmacological...	18 Years -	City of Hope Medical Center
Erlotinib and Temsirolimus in Treating Patients With Recurrent Malignant Glioma	NCT00112736	Adult Anaplasti... Adult Anaplasti... Adult Diffuse A... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Mixed Gli... Adult Pilocytic... Adult Pineal Gl... Adult Subependy... Recurrent Adult...	erlotinib temsirolimus therapeutic con... laboratory biom... pharmacological...	18 Years -	National Cancer Institute (NCI)
Levetiracetam or Pregabalin in Treating Seizures in Patients Undergoing Chemotherapy and/or Radiation Therapy For Primary Brain Tumors	NCT00629889	Brain and Centr... Seizure	levetiracetam pregabalin	18 Years -	Centre Hospitalier Universitaire Vaudois
Imatinib Mesylate, Vatalanib, and Hydroxyurea in Treating Patients With Recurrent or Relapsed Malignant Glioma	NCT00387933	Brain and Centr...	hydroxyurea imatinib mesyla... vatalanib	18 Years -	Duke University
Temozolomide in Treating Patients With Low-Grade Glioma	NCT00313729	CNS Tumor, Adul...	temozolomide	18 Years - 120 Years	University of California, San Francisco
Lonafarnib and Temozolomide in Treating Patients With Recurrent Primary Supratentorial Gliomas	NCT00083096	Brain and Centr...	lonafarnib temozolomide	18 Years -	European Organisation for Research and Treatment of Cancer - EORTC
Study of Blood Samples and Risk of Infection in Patients With Newly Diagnosed Malignant Supratentorial Astrocytoma	NCT00999622	Brain and Centr... Infection	laboratory biom... questionnaire a...	18 Years -	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Bevacizumab in Recurrent Grade II and III Glioma	NCT01164189	Central Nervous...	Bevacizumab Temozolomide	18 Years -	European Organisation for Research and Treatment of Cancer - EORTC
Temozolomide in Treating Patients With Low-Grade Glioma	NCT00313729	CNS Tumor, Adul...	temozolomide	18 Years - 120 Years	University of California, San Francisco
Veliparib and Temozolomide in Treating Patients With Recurrent Glioblastoma	NCT01026493	Brain and Centr...	temozolomide 60... temozolomide 75... ABT-888 20 mg x... ABT-888 40 mg x... Temozolomide 15... ABT-888 40 mg x...	18 Years - 120 Years	Radiation Therapy Oncology Group

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: